Relationship between chromosomal aberrations and gene expressions in the p53 pathway in chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is a neoplasm characterized by excessive accumulation of B lymphocytes in the peripheral blood, bone marrow and lymph nodes. We assessed the expressions of 22 genes in the p53 pathway in 30 CLL patients and 15 healthy subjects by a RT2 Profiler PCR (polymerase chai...
Saved in:
Published in | Balkan journal of medical genetics Vol. 23; no. 1; pp. 15 - 24 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Sofia
Sciendo
26.08.2020
De Gruyter Poland |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Chronic lymphocytic leukemia (CLL) is a neoplasm characterized by excessive accumulation of B lymphocytes in the peripheral blood, bone marrow and lymph nodes. We assessed the expressions of 22 genes in the p53 pathway in 30 CLL patients and 15 healthy subjects by a RT2 Profiler PCR (polymerase chain reaction) Array technique and their relation to cytogenetic aberrations detected by fluorescent
hybridization (FISH). Our Student’s
-test results indicated that
and BCL2 genes were statistically significant (
<0.001). For six genes
and
were not statistically significant. The
and
genes were found to be upregulated by the 2
(relative fold change in gene expression) method. The highest up-regulation was detected in
and
genes, 10.22- and 8.51-fold, respectively. On the other hand, the
gene with a fold regulation of 1.84 was found to the highest downregulation. Overall, the
and
genes are related to the mechanism of the disease in the p53 pathway and may be an important predictor of the prognosis of the disease. The
gene may be associated with increased risk of developing CLL. We suggest that the
gene may be considered as a marker associated with CLL disease. The
gene expression seems to play a protective role in CLL. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ISSN: | 1311-0160 1311-0160 2199-5761 |
DOI: | 10.2478/bjmg-2020-0007 |